Enovis CORP
ENOV · XNYSCIK 1420800fmd_1S7K1TWT78D1FHXMZVTVGN75T7Manufacturing · Orthopedic, Prosthetic & Surgical Appliances & SuppliesTemplate: Standard
Coverage: Jan 01, 2009 to Oct 02, 2026, 68 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 3,186 | 1,937 | 2,193 | 3,327 | 1,121 | 1,426 | 1,563 | 1,707 | 2,108 | 2,248 |
| Cost of revenue | 2,193 | 1,266 | 1,464 | 1,926 | 517 | 649 | 694 | 716 | 927 | 903 |
| Gross profit | 992 | 672 | 729 | 1,401 | 604 | 778 | 869 | 991 | 1,181 | 1,345 |
| Realized investment gains (losses) | 0 | 0 | (10) | 0 | 0 | 0 | 9 | 0 | 0 | – |
| Provision for credit losses | – | – | – | – | 8 | 3 | 3 | (5) | 11 | 3 |
| Research and development | – | – | – | – | 34 | 49 | 61 | 75 | 91 | 120 |
| Selling, general and administrative | 697 | 501 | 549 | 1,132 | 515 | 666 | 773 | 830 | 1,027 | 1,070 |
| Operating income | 237 | 136 | 152 | 204 | (66) | (63) | (71) | (66) | (776) | (1,124) |
| Interest expense | 30 | 40 | 49 | 120 | 53 | 29 | 24 | 20 | 57 | 35 |
| Other non-operating income (expense) | – | – | – | – | – | 0 | 2 | 26 | 10 | (0) |
| Income before taxes | 207 | 49 | 92 | 50 | (119) | (122) | (2) | (67) | (823) | (1,159) |
| Income tax expense | 52 | 2 | (30) | 32 | (45) | (20) | 36 | (13) | 4 | 22 |
| Net income from continuing operations | 155 | 46 | 122 | 19 | (74) | (102) | (38) | (54) | (827) | (1,182) |
| Net income | 128 | 151 | 140 | (528) | 43 | 72 | (13) | (33) | (825) | (1,184) |
| Net income to common shareholders | 138 | 45 | 169 | – | – | – | – | – | – | – |